Zurueck zur Suche

Reporte zur Charge UJ794AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

2Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
OH 1 PA 1

VAERS 2679145

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ794AA

gering
Staat
OH
Alter
0,8
Geschlecht
M
Eingang
05.09.2023
Impfdatum
08.06.2023
Beginn
08.06.2023
Tage bis Beginn
0,0
Dosis
4
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered No adverse event Wrong product administered

Symptomtext

patient was supposed to receive a dose of plain acthib (prp-t), but consumer got hib conjugated with dtap and a separate dtap as well with no reported adverse event; patient was supposed to receive a dose of plain acthib (prp-t), but consumer got hib conjugated with dtap and a separate dtap as well with no reported adverse event; Initial information received on 28-Aug-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 1 years old male patient who was supposed to receive a dose of plain HIB (PRP/T) vaccine [ACT-HIB] but consumer got hib conjugated with dtap and a separate dtap as well with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (DTAP) for Prophylactic vaccination (immunization). On 08-Jun-2023, the patient received a dose 4 dose 0.5mL but consumer got it twice making it 1 mL of suspect HIB (PRP/T) Vaccine Powder and solvent for solution for injection lot UJ794AA expiry date: 08-Oct-2023 via intramuscular route in the thigh not specified for Immunization. On 08-JUN-2023 the patient was supposed to receive a dose of plain acthib (prp-t), but consumer got hib conjugated with dtap and a separate dtap as well with no reported adverse event (wrong product administered) (extra dose administered) on the same day following the administration of HIB (PRP/T) Vaccine. Action taken was not applicable. At time of reporting, the outcome was Unknown for the events. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
DTAP
Allergien
-
Vorherige Impfungen
-

VAERS 2645168

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ794AA

gering
Staat
PA
Alter
0,5
Geschlecht
M
Eingang
14.06.2023
Impfdatum
09.06.2023
Beginn
09.06.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product preparation issue

Symptomtext

ActHib was reconstituted with sterile water for injection, rather than with the included diluent of 0.4% saline and the dose was then administered with no reported adverse event; Initial information received on 09-Jun-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 6 months old male patient who had acthib was reconstituted with sterile water for injection, rather than with the included diluent of 0.4% saline and the dose was then administered with no reported adverse event after receiving vaccine hib (prp/t) vaccine [act-hib]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (dtap) for immunisation; rotavirus vaccine (rotavirus vaccine) for immunisation; and hepatitis b vaccine (hepatitis b vaccine) for Immunisation. On 09-Jun-2023, the patient received a dose of suspect hib (prp/t) vaccine, Powder and solvent for solution for injection lot UJ794AA, 08-Oct-2023 via intramuscular route in unknown administration site for Immunization. On 09-Jun-2023 the patient developed a non-serious acthib was reconstituted with sterile water for injection, rather than with the included diluent of 0.4% saline and the dose was then administered with no reported adverse event (product preparation error) (latency: same day). Lab data was not reported. Action taken was not applicable. Outcome: Unknown for the event acthib was reconstituted with sterile water for injection, rather than with the included diluent of 0.4% saline and the dose was then administered with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
DTAP; ROTAVIRUS VACCINE; HEPATITIS B VACCINE
Allergien
-
Vorherige Impfungen
-